Coronavirus Update #193
Quality Tips from HFAM Associate Member Eurofins:
 
Coronavirus Wastewater Testing as an early warning method of a potential SARS-CoV-2 outbreak
  • Studies demonstrate that the presence of the virus in wastewater can be a strong indicator of the presence of the virus in a given place or community, before any indication of symptoms in infected people
  • Through regular wastewater testing and on-going monitoring of your facility, you can add another indicator related to the potential presence of the virus within your teams and environment and tailor your additional testing programs
  • This is a non-invasive method of monitoring coronavirus outbreaks

 
Coronavirus Worn Mask Testing
  • Testing of disposable non-medial masks presents a unique opportunity to collect information about the presence of SARS-CoV-2 in a population such as a work shift, wing of facility or residents in a non-invasive way
  • Worn mask testing is not a replacement for clinical testing, however it offers additional tools and strategies to keep the residence / workplace safe and to reduce or avoid spreading the disease
  • Worn mask testing requires no health care professional for sampling, it is easy and cost effective
  • This is a non-invasive method of monitoring coronavirus outbreaks

 
  • Testing for coronavirus on surfaces can identify possible contamination in high-touch areas in your facility. It can also be a means to verify, validate, and monitor the effectiveness of your sanitation and hygiene practices
  • Contact surface testing also shows your residents, their loved ones, employees and stakeholders your concern for their safety and protects your brand
  • This is a non-invasive method of monitoring coronavirus outbreaks

For all of Eurofins' COVID-19 testing solutions, please CLICK HERE.

If you have any questions or would like additional information please contact
Karen Gerwitz at 716-206-9874 or karengerwitz@eurofinsus.com
More Information

Eurofins, an associate HFAM member and trusted global network of over 800 laboratories is helping facilities comply with COVID-19 testing requirements for staff and residents by offering direct bill RT-PCR testing for $75 per test for HFAM members. This price includes:
 
  • Your choice of nasal or nasopharyngeal swabs
  • Test kits with the supplies needed to administer the testing, including pre-labeled return packaging materials
  • Physician ordering if needed
  • Priority shipping via FedEx of kits both to your facility and back to the lab for analysis
  • 48 hour testing turn-around time*
  • Access to our user-friendly portal for electric entering and reporting
 
Eurofins also offers this testing for third party billing at $100 per test upon request.

To set up your facility, or if you have any questions on the process, please contact Karen Gerwitz at karengerwitz@eurofinsus.com or 716-206-9874. Make sure to reference that you are an HFAM member to get the above discounted rate.
 
*Clinical Enterprises reports 80% of test results out within 24 hours from time of receipt at the lab. Eurofins states a 48 hour turn-around time to give cushion and deliver on their commitment.
Did you miss HFAM's previous alerts?

Visit our website to view all previous HFAM alerts, as well as guidance
from our federal and state partners.
Thank you.

We cannot thank you enough for the dedication and diligence in doing all that you can for the residents in your communities. HFAM continues to monitor the COVID-19 pandemic with our state and national partners and will do all we can to support you during this time.